Compare · BMGL vs LHCG
BMGL vs LHCG
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and LHC Group (LHCG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and LHCG operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LHCG carries a market cap of $3.72B.
- BMGL has hit the wire 6 times in the past 4 weeks while LHCG has been quiet.
- LHCG has more recent analyst coverage (21 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- LHC Group
- Price
- $0.60-3.08%
- $169.80+0.47%
- Market cap
- -
- $3.72B
- 1M return
- -10.31%
- -
- 1Y return
- -85.73%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2005
- News (4w)
- 6
- 0
- Recent ratings
- 0
- 21
LHC Group
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy and other non-related facilities, nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to accountable care organizations. As of December 31, 2020, it operated 537 home health services locations, 120 hospice locations, 124 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 12 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
Latest BMGL
- SEC Form 3 filed by new insider Soong Kwek Yoon
- SEC Form 3 filed by new insider Lu Jianing Jn
- SEC Form 3 filed by new insider Chen Tony
- SEC Form 3 filed by new insider Chhoa Darren Yen Feng
- SEC Form 3 filed by new insider Tan Boon Chye
- SEC Form 3 filed by new insider Fung Keng Leong
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- Compliance With Nasdaq Periodic Filing Requirement
- Amendment: SEC Form 20-F/A filed by Basel Medical Group Ltd
Latest LHCG
- SEC Form 4: Reed W Earl Iii returned $23,595,490 worth of shares to the company (138,797 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Nixon Ronald T returned $4,607,000 worth of shares to the company (27,100 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Azare Monica F returned $5,185,000 worth of shares to the company (30,500 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Goldberg Jonathan returned $9,770,240 worth of shares to the company (57,472 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Mackel Dale returned $3,066,630 worth of shares to the company (18,039 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Indest John L returned $5,941,160 worth of shares to the company (34,948 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Gachassin Nicholas Iii returned $2,696,200 worth of shares to the company (15,860 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Proffitt Joshua L. returned $7,809,290 worth of shares to the company (117,443 units at $66.49), closing all direct ownership in the company
- SEC Form 4: Myers Keith G returned $136,814,640 worth of shares to the company (903,558 units at $151.42), closing all direct ownership in the company
- SEC Form 4: Seymour Kimberly S returned $264,180 worth of shares to the company (5,595 units at $47.22), closing all direct ownership in the company